Combination of trastuzumab and pertuzumab with FOLFOXIRI as the neoadjuvant therapeutic tegimen for HER2-positive resectable metastatic colorectal cancer: The first case report - Hua-Yang Pang; Meng-Yua Yan; Xiu-Feng Chen; Hao Sun (Asian Journal of Surgery)